![Keith Barclay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith Barclay
Chief Investment Officer bei Elasmogen Ltd.
Profil
Keith Barclay currently works at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Principal from 2015.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Aktive Positionen von Keith Barclay
Unternehmen | Position | Beginn |
---|---|---|
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Private Equity Investor | 01.11.2015 |
Elasmogen Ltd.
![]() Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Chief Investment Officer | - |
Ausbildung von Keith Barclay
University of Aberdeen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Finance |
Elasmogen Ltd.
![]() Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Health Technology |